Marcus N. Scherer

3.6k total citations · 1 hit paper
78 papers, 2.5k citations indexed

About

Marcus N. Scherer is a scholar working on Surgery, Hepatology and Epidemiology. According to data from OpenAlex, Marcus N. Scherer has authored 78 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Surgery, 36 papers in Hepatology and 18 papers in Epidemiology. Recurrent topics in Marcus N. Scherer's work include Organ Transplantation Techniques and Outcomes (28 papers), Liver Disease and Transplantation (26 papers) and Renal Transplantation Outcomes and Treatments (16 papers). Marcus N. Scherer is often cited by papers focused on Organ Transplantation Techniques and Outcomes (28 papers), Liver Disease and Transplantation (26 papers) and Renal Transplantation Outcomes and Treatments (16 papers). Marcus N. Scherer collaborates with scholars based in Germany, United States and Belgium. Marcus N. Scherer's co-authors include Hans J. Schlitt, Stefan Farkas, Andreas A. Schnitzbauer, Martin Loss, Aiman Obed, Alexander Kroemer, Stefan Fichtner‐Feigl, Silvio Nadalin, Sven Arke Lang and Edward K. Geissler and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Hepatology.

In The Last Decade

Marcus N. Scherer

75 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Right Portal Vein Ligation Combined With In Situ Splitting Induces Rapid Left Lateral Liver Lobe Hypertrophy Enabling 2-Staged Extended Right Hepatic Resection in Small-for-Size Settings

2012 863 citations Andreas A. Schnitzbauer, Silvio Nadalin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marcus N. Scherer Germany	23	1.3k	1.2k	877	520	309	78	2.5k
Filoména Conti France	26	1.0k 0.8×	1.0k 0.9×	806 0.9×	323 0.6×	295 1.0×	87	2.3k
Takeo Toshima Japan	31	1.6k 1.2×	1.2k 1.0×	1.1k 1.2×	877 1.7×	321 1.0×	182	3.3k
Aya Miyagawa‐Hayashino Japan	25	873 0.7×	915 0.8×	588 0.7×	415 0.8×	227 0.7×	90	2.1k
Taketoshi Suehiro Japan	28	1.3k 1.0×	1.4k 1.2×	555 0.6×	244 0.5×	151 0.5×	115	2.1k
Kazuki Takeishi Japan	28	1.2k 0.9×	848 0.7×	729 0.8×	742 1.4×	215 0.7×	108	2.4k
Michihiro Hayashi Japan	30	3.0k 2.3×	3.0k 2.6×	1.0k 1.2×	665 1.3×	258 0.8×	118	4.3k
Mingqing Xu China	28	1.3k 1.0×	1000 0.8×	732 0.8×	451 0.9×	138 0.4×	147	2.7k
Yuzo Umeda Japan	26	680 0.5×	1.0k 0.9×	377 0.4×	791 1.5×	180 0.6×	167	2.0k
Yohei Mano Japan	24	807 0.6×	656 0.6×	483 0.6×	1.0k 2.0×	311 1.0×	77	2.1k
Steven D. Colquhoun United States	24	1.3k 1.0×	1.2k 1.0×	710 0.8×	307 0.6×	90 0.3×	65	2.2k

Countries citing papers authored by Marcus N. Scherer

Since Specialization

Citations

This map shows the geographic impact of Marcus N. Scherer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus N. Scherer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus N. Scherer more than expected).

Fields of papers citing papers by Marcus N. Scherer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcus N. Scherer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus N. Scherer. The network helps show where Marcus N. Scherer may publish in the future.

Co-authorship network of co-authors of Marcus N. Scherer

This figure shows the co-authorship network connecting the top 25 collaborators of Marcus N. Scherer. A scholar is included among the top collaborators of Marcus N. Scherer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcus N. Scherer. Marcus N. Scherer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kandulski, Arne, I Zuber-Jerger, Marcus N. Scherer, et al.. (2025). The Presence and Significance of Bacteria and Fungi in Bile Aspirated During ERC—A Retrospective Analysis. Biomedicines. 13(5). 1255–1255.

Moleda, L, et al.. (2018). Safety of Direct-Acting Antiviral Therapy Regarding Renal Function in Post–Liver Transplant Patients Infected with Hepatitis C Virus and a 100% 12-Week Sustained Virologic Response—A Single-Center Study. Transplantation Proceedings. 50(5). 1444–1450. 3 indexed citations

Czigány, Zoltán, Marcus N. Scherer, Johann Pratschke, et al.. (2018). Technical Aspects of Orthotopic Liver Transplantation—a Survey-Based Study Within the Eurotransplant, Swisstransplant, Scandiatransplant, and British Transplantation Society Networks. Journal of Gastrointestinal Surgery. 23(3). 529–537. 23 indexed citations

Agha, Ayman, Marcus N. Scherer, Christian Moser, et al.. (2016). Living-donor parathyroid allotransplantation for therapy-refractory postsurgical persistent hypoparathyroidism in a nontransplant recipient – three year results: a case report. BMC Surgery. 16(1). 51–51. 16 indexed citations

Bauer, Sabrina, Kristina Eisinger, Reiner Wiest, et al.. (2012). Connective tissue growth factor level is increased in patients with liver cirrhosis but is not associated with complications or extent of liver injury. Regulatory Peptides. 179(1-3). 10–14. 9 indexed citations

Werner, Jens, Corinna N. Lang, Marcus N. Scherer, et al.. (2011). Distribution of intrahepatic T, NK and CD3+CD56+NKT cells alters after liver transplantation: Shift from innate to adaptive immunity?. Transplant Immunology. 25(1). 27–33. 10 indexed citations

Agha, Ayman, Martin Loss, Hans J. Schlitt, & Marcus N. Scherer. (2011). Recurrence of secondary hyperparathyroidism in patients after total parathyroidectomy with autotransplantation: technical and therapeutic aspects. European Archives of Oto-Rhino-Laryngology. 269(5). 1519–1525. 30 indexed citations

Bauer, Sabrina, Thomas S. Weiß, Reiner Wiest, et al.. (2011). Soluble CD163 is not increased in visceral fat and steatotic liver and is even suppressed by free fatty acids in vitro. Experimental and Molecular Pathology. 91(3). 733–739. 16 indexed citations

Schlitt, Hans J., M. Loss, Marcus N. Scherer, et al.. (2011). Aktuelle Entwicklungen der Lebertransplantation in Deutschland: MELD-basierte Organallokation und „incentives” für Transplantationszentren. Zeitschrift für Gastroenterologie. 49(1). 30–38. 56 indexed citations

10.

Kirchner, Gabi I., Marcus N. Scherer, Aiman Obed, et al.. (2010). Outcome of patients with ischemic-like cholangiopathy with secondary sclerosing cholangitis after liver transplantation. Scandinavian Journal of Gastroenterology. 46(4). 471–478. 33 indexed citations

11.

Doenecke, Axel, et al.. (2010). AAV plasmid DNA simplifies liver‐directed in vivo gene therapy: comparison of expression levels after plasmid DNA‐, adeno‐associated virus‐ and adenovirus‐mediated liver transfection. The Journal of Gene Medicine. 12(10). 810–817. 4 indexed citations

12.

Weigert, Johanna, Markus Neumeier, Josef Wanninger, et al.. (2009). Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clinical Endocrinology. 72(3). 342–348. 246 indexed citations

13.

Doenecke, Axel, et al.. (2009). Pre‐existent portal vein thrombosis in liver transplantation: influence of pre‐operative disease severity. Clinical Transplantation. 24(1). 48–55. 37 indexed citations

14.

Agha, Ayman, Marcus N. Scherer, Matthias Woenckhaus, et al.. (2007). Effectiveness of parathyroid-hormone measurement in detecting patients with multiple gland disease causing primary hyperparathyroidism. Langenbeck s Archives of Surgery. 392(6). 703–708. 8 indexed citations

15.

Graeb, Christian, Marcus N. Scherer, Alexander Kroemer, Karl‐Walter Jauch, & Edward K. Geissler. (2002). Hepatocyte expression of soluble donor MHC class I antigen via gene transfer inhibits multiple aspects of the antidonor immune response in fully sensitized rat transplant recipients. Human Immunology. 63(10). 948–954. 2 indexed citations

16.

Graeb, Christian, et al.. (2002). Expression of high levels of soluble allogeneic major histocompatability complex class i antigen by adenoviral gene transfer strongly inhibits allospecific cytotoxic t lymphocytes in vivo. Transplantation Proceedings. 34(5). 1398–1399. 3 indexed citations

17.

Scherer, Marcus N., Christian Graeb, Thomas S. Weiß, et al.. (2002). THE ANTINEOPLASTIC DRUG PACLITAXEL HAS IMMUNOSUPPRESSIVE PROPERTIES THAT CAN EFFECTIVELY PROMOTE ALLOGRAFT SURVIVAL IN A RAT HEART TRANSPLANT MODEL1. Transplantation. 73(2). 216–223. 22 indexed citations

18.

Graeb, Christian, Marcus N. Scherer, Joachim Andrassy, et al.. (2002). Use of an adenoviral vector to express soluble donor-major histocompatibility complex molecules capable of suppressing the immune response in rat transplant recipients. Human Immunology. 63(10). 844–852. 12 indexed citations

19.

Graeb, Christian, et al.. (2001). Soluble donor MHC class I gene therapy prevents accelerated heart allograft rejection in actively sensitized rat recipients. Transplantation Proceedings. 33(1-2). 579–580.

20.

Geissler, Edward K., et al.. (2000). Effective Use of Donor MHC Class I Gene Therapy in Organ Transplantation: Prevention of Antibody-Mediated Hyperacute Heart Allograft Rejection in Highly Sensitized Rat Recipients. Human Gene Therapy. 11(3). 459–469. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact